PL388833A1 - Composition for reducing body weight or inhibiting body weight gain - Google Patents
Composition for reducing body weight or inhibiting body weight gainInfo
- Publication number
- PL388833A1 PL388833A1 PL388833A PL38883309A PL388833A1 PL 388833 A1 PL388833 A1 PL 388833A1 PL 388833 A PL388833 A PL 388833A PL 38883309 A PL38883309 A PL 38883309A PL 388833 A1 PL388833 A1 PL 388833A1
- Authority
- PL
- Poland
- Prior art keywords
- body weight
- composition
- inhibiting
- reducing
- weight gain
- Prior art date
Links
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PL388833A PL388833A1 (en) | 2009-08-18 | 2009-08-18 | Composition for reducing body weight or inhibiting body weight gain |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PL388833A PL388833A1 (en) | 2009-08-18 | 2009-08-18 | Composition for reducing body weight or inhibiting body weight gain |
Publications (1)
Publication Number | Publication Date |
---|---|
PL388833A1 true PL388833A1 (en) | 2011-02-28 |
Family
ID=43798116
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL388833A PL388833A1 (en) | 2009-08-18 | 2009-08-18 | Composition for reducing body weight or inhibiting body weight gain |
Country Status (1)
Country | Link |
---|---|
PL (1) | PL388833A1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2527591A (en) * | 2014-06-27 | 2015-12-30 | Gw Pharma Ltd | 7-hydroxy cannabidiol (7-OH-CBD) for use in the treatment of non-alcoholic fatty liver disease (NAFLD) |
-
2009
- 2009-08-18 PL PL388833A patent/PL388833A1/en not_active Application Discontinuation
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2527591A (en) * | 2014-06-27 | 2015-12-30 | Gw Pharma Ltd | 7-hydroxy cannabidiol (7-OH-CBD) for use in the treatment of non-alcoholic fatty liver disease (NAFLD) |
US10039724B2 (en) | 2014-06-27 | 2018-08-07 | GW Research Limited | 7-hydroxy cannabidiol (7-OH-CBD) for use in the treatment of non-alcoholic fatty liver disease (NAFLD) |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1246216B (en) | Antimicrobial composition | |
GB2473460B (en) | Antimicrobial Composition | |
IL215344A0 (en) | Vehicle having rolling compensation | |
IL214706A (en) | Compositions for preventing cardiac arrhythmia | |
GB0908129D0 (en) | Composition | |
EP2421369A4 (en) | Fungicidal composition | |
GB0911428D0 (en) | Composition | |
GB0909362D0 (en) | Composition | |
GB0908642D0 (en) | Composition | |
GB0901966D0 (en) | Composition | |
GB0800383D0 (en) | Weight reducing compounds | |
EP2394634A4 (en) | Hesperidin-containing composition | |
GB0906779D0 (en) | Composition | |
IL218500A0 (en) | Apogossypolone derivatives as anticaner agents | |
EP2503179A4 (en) | Braking structure for pivoting body | |
GB0904941D0 (en) | Composition | |
ZA201108658B (en) | Fungicidal composition | |
PL2506827T3 (en) | Lubricious Aqueous Composition | |
EP2444061A4 (en) | Apigenin-containing composition | |
PL2405753T3 (en) | Insect-repellent composition | |
GB0911294D0 (en) | Composition | |
GB0904942D0 (en) | Composition | |
EP2488183A4 (en) | Composition for inhibiting tgf- comprising imidazopurine derivatives | |
ZA201105265B (en) | Platform body | |
PL2503883T3 (en) | Disinfectant composition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
REFS | Decisions on refusal to grant patents (taken after the publication of the particulars of the applications) |